Annika L. Gable
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Annika L. Gable has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Ashley R. Maceli
3 shared publications- Christian von Mering
University of Zürich
3 shared publications Damian Szklarczyk
Department of Molecular Life Sciences and Swiss Institute of Bioinformatics, University of Zurich, 8057 Zurich, Switzerland
3 shared publicationsJohn E. Wilkinson
3 shared publicationsMar Soto
3 shared publications- Nadezhda Tsankova Doncheva
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark
3 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 16 September 2021
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 49 (18) , 10800
Correction to ‘The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets’
Nucleic Acids Research, 2021, 49(Database): D605–D612, https://doi.org/10.1093/nar/gkaa1074
- 16 September 2021
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 49 (18) , 10800
Top Cited PapersOpen AccessCorrection to ‘The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets’
Nucleic Acids Research, 2021, 49(Database): D605–D612, https://doi.org/10.1093/nar/gkaa1074
- Top Cited PapersOpen Access
- 25 November 2020
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 49 (D1) , D605-D612
The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets
Cellular life depends on a complex web of functional associations between biomolecules. Among these associations, protein–protein interactions are particularly important due to their versatility, specificity and adaptability. The STRING database aims to integrate all known and predicted associations between proteins, including both physical interactions as well as functional associations. To achieve this, STRING collects and scores evidence from a number of sources: (i) automated text mining of the scientific literature, (ii) databases of interaction experiments and annotated complexes/pathways, (iii) computational interaction predictions from co-expression and from conserved genomic context and (iv) systematic transfers of interaction evidence from one organism to another. STRING aims for wide coverage; the upcoming version 11.5 of the resource will contain more than 14 000 organisms. In this update paper, we describe changes to the text-mining system, a new scoring-mode for physical interactions, as well as extensive user interface features for customizing, extending and sharing protein networks. In addition, we describe how to query STRING with genome-wide, experimental data, including the automated detection of enriched functionalities and potential biases in the user's query data. The STRING resource is available online, at https://string-db.org/.
- 25 November 2020
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 49 (D1) , D605-D612
Top Cited PapersOpen AccessThe STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets
Cellular life depends on a complex web of functional associations between biomolecules. Among these associations, protein–protein interactions are particularly important due to their versatility, specificity and adaptability. The STRING database aims to integrate all known and predicted associations between proteins, including both physical interactions as well as functional associations. To achieve this, STRING collects and scores evidence from a number of sources: (i) automated text mining of the scientific literature, (ii) databases of interaction experiments and annotated complexes/pathways, (iii) computational interaction predictions from co-expression and from conserved genomic context and (iv) systematic transfers of interaction evidence from one organism to another. STRING aims for wide coverage; the upcoming version 11.5 of the resource will contain more than 14 000 organisms. In this update paper, we describe changes to the text-mining system, a new scoring-mode for physical interactions, as well as extensive user interface features for customizing, extending and sharing protein networks. In addition, we describe how to query STRING with genome-wide, experimental data, including the automated detection of enriched functionalities and potential biases in the user's query data. The STRING resource is available online, at https://string-db.org/.
- Top Cited PapersOpen Access
- 22 November 2018
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 47 (D1) , D607-D613
STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Proteins and their functional interactions form the backbone of the cellular machinery. Their connectivity network needs to be considered for the full understanding of biological phenomena, but the available information on protein–protein associations is incomplete and exhibits varying levels of annotation granularity and reliability. The STRING database aims to collect, score and integrate all publicly available sources of protein–protein interaction information, and to complement these with computational predictions. Its goal is to achieve a comprehensive and objective global network, including direct (physical) as well as indirect (functional) interactions. The latest version of STRING (11.0) more than doubles the number of organisms it covers, to 5090. The most important new feature is an option to upload entire, genome-wide datasets as input, allowing users to visualize subsets as interaction networks and to perform gene-set enrichment analysis on the entire input. For the enrichment analysis, STRING implements well-known classification systems such as Gene Ontology and KEGG, but also offers additional, new classification systems based on high-throughput text-mining as well as on a hierarchical clustering of the association network itself. The STRING resource is available online at https://string-db.org/.
- 22 November 2018
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 47 (D1) , D607-D613
Top Cited PapersOpen AccessSTRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Proteins and their functional interactions form the backbone of the cellular machinery. Their connectivity network needs to be considered for the full understanding of biological phenomena, but the available information on protein–protein associations is incomplete and exhibits varying levels of annotation granularity and reliability. The STRING database aims to collect, score and integrate all publicly available sources of protein–protein interaction information, and to complement these with computational predictions. Its goal is to achieve a comprehensive and objective global network, including direct (physical) as well as indirect (functional) interactions. The latest version of STRING (11.0) more than doubles the number of organisms it covers, to 5090. The most important new feature is an option to upload entire, genome-wide datasets as input, allowing users to visualize subsets as interaction networks and to perform gene-set enrichment analysis on the entire input. For the enrichment analysis, STRING implements well-known classification systems such as Gene Ontology and KEGG, but also offers additional, new classification systems based on high-throughput text-mining as well as on a hierarchical clustering of the association network itself. The STRING resource is available online at https://string-db.org/.
- Open Access
- 5 April 2018
- Published by Springer Nature in Nature
- Vol. 556 (7699) , 135
Erratum: Asparagine bioavailability governs metastasis in a model of breast cancer
Nature 554, 378–381 (2018); doi:10.1038/nature25465 In this Letter, several errors were inadvertently introduced during the production process. In Fig. 3d, the blue bars should be labelled ‘l-asparaginase’ rather than ‘l-asparagine’. In the main text, “These were collected onto Matrigel…” should be “These were placed onto Matrigel…”, and in the Methods, ‘corresponding proteins’ should be ‘corresponding peptides’ in the text: “…proteins were removed from subsequent analysis if fewer than 5 corresponding peptides were identified in any sample.
- 5 April 2018
- Published by Springer Nature in Nature
- Vol. 556 (7699) , 135
Open AccessErratum: Asparagine bioavailability governs metastasis in a model of breast cancer
Nature 554, 378–381 (2018); doi:10.1038/nature25465 In this Letter, several errors were inadvertently introduced during the production process. In Fig. 3d, the blue bars should be labelled ‘l-asparaginase’ rather than ‘l-asparagine’. In the main text, “These were collected onto Matrigel…” should be “These were placed onto Matrigel…”, and in the Methods, ‘corresponding proteins’ should be ‘corresponding peptides’ in the text: “…proteins were removed from subsequent analysis if fewer than 5 corresponding peptides were identified in any sample.
- Top Cited Papers
- 7 February 2018
- Published by Springer Nature in Nature
- Vol. 554 (7692) , 378-381
Asparagine bioavailability governs metastasis in a model of breast cancer
In a mouse model of breast cancer, asparagine bioavailability strongly influences metastasis and this is correlated with the production of proteins that regulate the epithelial-to-mesenchymal transition, which provides at least one potential mechanism for how a single amino acid could regulate metastatic progression. Not all cells that derive from a primary tumour contribute to metastasis—the progression of cancer into other parts of the body. Gregory Hannon and colleagues find determinants of metastatic potential in a mouse model of breast cancer. They find that expression of the metabolic enzyme asparagine synthetase is associated with metastasis formation. Decreasing asparagine availability by treatment with ʟ-asparaginase or by dietary restriction reduced the development of metastasis. The authors show that asparagine availability promotes an epithelial-to-mesenchymal transition, a process that has been linked to metastasis. Using a functional model of breast cancer heterogeneity, we previously showed that clonal sub-populations proficient at generating circulating tumour cells were not all equally capable of forming metastases at secondary sites1. A combination of differential expression and focused in vitro and in vivo RNA interference screens revealed candidate drivers of metastasis that discriminated metastatic clones. Among these, asparagine synthetase expression in a patient’s primary tumour was most strongly correlated with later metastatic relapse. Here we show that asparagine bioavailability strongly influences metastatic potential. Limiting asparagine by knockdown of asparagine synthetase, treatment with l-asparaginase, or dietary asparagine restriction reduces metastasis without affecting growth of the primary tumour, whereas increased dietary asparagine or enforced asparagine synthetase expression promotes metastatic progression. Altering asparagine availability in vitro strongly influences invasive potential, which is correlated with an effect on proteins that promote the epithelial-to-mesenchymal transition. This provides at least one potential mechanism for how the bioavailability of a single amino acid could regulate metastatic progression.
- 7 February 2018
- Published by Springer Nature in Nature
- Vol. 554 (7692) , 378-381
Top Cited PapersAsparagine bioavailability governs metastasis in a model of breast cancer
In a mouse model of breast cancer, asparagine bioavailability strongly influences metastasis and this is correlated with the production of proteins that regulate the epithelial-to-mesenchymal transition, which provides at least one potential mechanism for how a single amino acid could regulate metastatic progression. Not all cells that derive from a primary tumour contribute to metastasis—the progression of cancer into other parts of the body. Gregory Hannon and colleagues find determinants of metastatic potential in a mouse model of breast cancer. They find that expression of the metabolic enzyme asparagine synthetase is associated with metastasis formation. Decreasing asparagine availability by treatment with ʟ-asparaginase or by dietary restriction reduced the development of metastasis. The authors show that asparagine availability promotes an epithelial-to-mesenchymal transition, a process that has been linked to metastasis. Using a functional model of breast cancer heterogeneity, we previously showed that clonal sub-populations proficient at generating circulating tumour cells were not all equally capable of forming metastases at secondary sites1. A combination of differential expression and focused in vitro and in vivo RNA interference screens revealed candidate drivers of metastasis that discriminated metastatic clones. Among these, asparagine synthetase expression in a patient’s primary tumour was most strongly correlated with later metastatic relapse. Here we show that asparagine bioavailability strongly influences metastatic potential. Limiting asparagine by knockdown of asparagine synthetase, treatment with l-asparaginase, or dietary asparagine restriction reduces metastasis without affecting growth of the primary tumour, whereas increased dietary asparagine or enforced asparagine synthetase expression promotes metastatic progression. Altering asparagine availability in vitro strongly influences invasive potential, which is correlated with an effect on proteins that promote the epithelial-to-mesenchymal transition. This provides at least one potential mechanism for how the bioavailability of a single amino acid could regulate metastatic progression.
- Open Access
- 16 April 2015
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 43 (W1) , W220-W224
webSDA: a web server to simulate macromolecular diffusional association
Macromolecular interactions play a crucial role in biological systems. Simulation of diffusional association (SDA) is a software for carrying out Brownian dynamics simulations that can be used to study the interactions between two or more biological macromolecules. webSDA allows users to run Brownian dynamics simulations with SDA to study bimolecular association and encounter complex formation, to compute association rate constants, and to investigate macromolecular crowding using atomically detailed macromolecular structures. webSDA facilitates and automates the use of the SDA software, and offers user-friendly visualization of results. webSDA currently has three modules: ‘SDA docking’ to generate structures of the diffusional encounter complexes of two macromolecules, ‘SDA association’ to calculate bimolecular diffusional association rate constants, and ‘SDA multiple molecules’ to simulate the diffusive motion of hundreds of macromolecules. webSDA is freely available to all users and there is no login requirement. webSDA is available at http://mcm.h-its.org/webSDA/.
- 16 April 2015
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 43 (W1) , W220-W224
Open AccesswebSDA: a web server to simulate macromolecular diffusional association
Macromolecular interactions play a crucial role in biological systems. Simulation of diffusional association (SDA) is a software for carrying out Brownian dynamics simulations that can be used to study the interactions between two or more biological macromolecules. webSDA allows users to run Brownian dynamics simulations with SDA to study bimolecular association and encounter complex formation, to compute association rate constants, and to investigate macromolecular crowding using atomically detailed macromolecular structures. webSDA facilitates and automates the use of the SDA software, and offers user-friendly visualization of results. webSDA currently has three modules: ‘SDA docking’ to generate structures of the diffusional encounter complexes of two macromolecules, ‘SDA association’ to calculate bimolecular diffusional association rate constants, and ‘SDA multiple molecules’ to simulate the diffusive motion of hundreds of macromolecules. webSDA is freely available to all users and there is no login requirement. webSDA is available at http://mcm.h-its.org/webSDA/.
- 8 April 2015
- Published by Springer Nature in Nature
- Vol. 520 (7547) , 358-362
A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis
Different clones of a mammary tumour cell line possess differential abilities to contribute to the formation of metastasis; the expression of Serpine2 and Slp1 proteins drives vascular mimicry and metastasis to the lung, with similar associations observed in human data sets, and these proteins also function as anticoagulants, thus further promoting extravasation of tumour cells. Using a mouse model of tumour heterogeneity that can be perturbed genetically to validate drivers of specific clonal behaviours, Elvin Wagenblast et al. demonstrate that different clones of a mammary tumour cell lines possess different abilities to contribute to the formation of metastasis. The expression of Serpine2 and Slpi proteins correlates with lung metastasis, and similar associations were observed in human datasets. Serpine2 and Slpi act as anticoagulants and also allow tumour cells to undergo vascular mimicry, whereby the tumour cells themselves form part of blood vessels and contribute to increased intravasation by building more leaky blood vessels. Cancer metastasis requires that primary tumour cells evolve the capacity to intravasate into the lymphatic system or vasculature, and extravasate into and colonize secondary sites1. Others have demonstrated that individual cells within complex populations show heterogeneity in their capacity to form secondary lesions2,3,4,5. Here we develop a polyclonal mouse model of breast tumour heterogeneity, and show that distinct clones within a mixed population display specialization, for example, dominating the primary tumour, contributing to metastatic populations, or showing tropism for entering the lymphatic or vasculature systems. We correlate these stable properties to distinct gene expression profiles. Those clones that efficiently enter the vasculature express two secreted proteins, Serpine2 and Slpi, which were necessary and sufficient to program these cells for vascular mimicry. Our data indicate that these proteins not only drive the formation of extravascular networks but also ensure their perfusion by acting as anticoagulants. We propose that vascular mimicry drives the ability of some breast tumour cells to contribute to distant metastases while simultaneously satisfying a critical need of the primary tumour to be fed by the vasculature. Enforced expression of SERPINE2 and SLPI in human breast cancer cell lines also programmed them for vascular mimicry, and SERPINE2 and SLPI were overexpressed preferentially in human patients that had lung-metastatic relapse. Thus, these two secreted proteins, and the phenotype they promote, may be broadly relevant as drivers of metastatic progression in human cancer.
- 8 April 2015
- Published by Springer Nature in Nature
- Vol. 520 (7547) , 358-362
A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis
Different clones of a mammary tumour cell line possess differential abilities to contribute to the formation of metastasis; the expression of Serpine2 and Slp1 proteins drives vascular mimicry and metastasis to the lung, with similar associations observed in human data sets, and these proteins also function as anticoagulants, thus further promoting extravasation of tumour cells. Using a mouse model of tumour heterogeneity that can be perturbed genetically to validate drivers of specific clonal behaviours, Elvin Wagenblast et al. demonstrate that different clones of a mammary tumour cell lines possess different abilities to contribute to the formation of metastasis. The expression of Serpine2 and Slpi proteins correlates with lung metastasis, and similar associations were observed in human datasets. Serpine2 and Slpi act as anticoagulants and also allow tumour cells to undergo vascular mimicry, whereby the tumour cells themselves form part of blood vessels and contribute to increased intravasation by building more leaky blood vessels. Cancer metastasis requires that primary tumour cells evolve the capacity to intravasate into the lymphatic system or vasculature, and extravasate into and colonize secondary sites1. Others have demonstrated that individual cells within complex populations show heterogeneity in their capacity to form secondary lesions2,3,4,5. Here we develop a polyclonal mouse model of breast tumour heterogeneity, and show that distinct clones within a mixed population display specialization, for example, dominating the primary tumour, contributing to metastatic populations, or showing tropism for entering the lymphatic or vasculature systems. We correlate these stable properties to distinct gene expression profiles. Those clones that efficiently enter the vasculature express two secreted proteins, Serpine2 and Slpi, which were necessary and sufficient to program these cells for vascular mimicry. Our data indicate that these proteins not only drive the formation of extravascular networks but also ensure their perfusion by acting as anticoagulants. We propose that vascular mimicry drives the ability of some breast tumour cells to contribute to distant metastases while simultaneously satisfying a critical need of the primary tumour to be fed by the vasculature. Enforced expression of SERPINE2 and SLPI in human breast cancer cell lines also programmed them for vascular mimicry, and SERPINE2 and SLPI were overexpressed preferentially in human patients that had lung-metastatic relapse. Thus, these two secreted proteins, and the phenotype they promote, may be broadly relevant as drivers of metastatic progression in human cancer.